IndraLab

Statements

Ibrutinib inhibits OTUD1. 1 / 1

| 1

➶

reach

"The FDA-approved drug ibrutinib preferentially reduces the tumorigenicity of OTUD1 high ovarian cancer cells."

38351029

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Ibrutinib inhibits OTUD1. 1 / 1

INDRA sources:

Databases

Reading